Personalizing surgical margins in retroperitoneal sarcomas: an update

References

• Stiller CA, Trama A, Serraino D, et al. . Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013;49:684–695
   PubMed Web of Science ®Google Scholar
• Raut CP, Pisters PW. Retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol. 2006;94:81–87.
   PubMed Web of Science ®Google Scholar
• Singer SMR, O’Sullivan B. Soft tissue sarcoma. In: DeVita LT Jr, Rosenberg SA, editors. Cancer: principles and practice of oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 1533–1577.
   Google Scholar
• Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006;106:1610–1616.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary Retroperitoneal Sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg 2016;263:1002–1009
   PubMed Web of Science ®Google Scholar
• Callegaro D, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther. 2015;15:553–567.
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397–402.
   PubMed Web of Science ®Google Scholar
• Ardoino I, Miceli R, Berselli M, et al. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer. 2010;116:2429–2436.
   PubMed Web of Science ®Google Scholar
• Raut CP, Miceli R, Strauss DC, et al. External validation of a multi-institutional retroperitoneal sarcoma nomogram. Cancer. 2016;122:1417–1424.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–1655.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23:1067–1073.
   PubMed Web of Science ®Google Scholar
• Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016;263:593–600.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miceli R, Allard MA, et al. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2015;22:1447–1454.
   PubMed Web of Science ®Google Scholar
• Dantey K, Schoedel K, Yergiyev O, et al. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas. Hum Pathol. 2017;66:86–92.
   PubMed Web of Science ®Google Scholar
• Gladdy RA, Qin LX, Moraco N, et al. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013;20:1851–1857.
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–37.
   PubMed Web of Science ®Google Scholar
• Toulmonde M, Bonvalot S, Meeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French sarcoma group. Ann Oncol. 2014;25:735–742.
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355–365.
   PubMed Web of Science ®Google Scholar
• van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234–238.
   PubMed Web of Science ®Google Scholar
• Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;97:698–706.
   PubMed Web of Science ®Google Scholar
• Bremjit PJ, Jones RL, Chai X, et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol. 2014;21:2150–2158.
   PubMed Web of Science ®Google Scholar
• Miah AB, Hannay J, Benson C, et al. Optimal management of primary retroperitoneal sarcoma: an update. Expert Rev Anticancer Ther. 2014;14:565–579.
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol. 2008;98:607–610.
   PubMed Web of Science ®Google Scholar
• Keung EZ, Hornick JL, Bertagnolli MM, et al. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014;218:206–217.
   PubMed Web of Science ®Google Scholar
• Cancer AJCo. AJCC cancer staging manual. Chicago: Springer; 2017.
   Google Scholar
• Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg. 2009;250:970–976.
   PubMed Web of Science ®Google Scholar
• Fisher SB, Chiang YJ, Feig BW, et al. An evaluation of the eighth edition of the American Joint Committee on Cancer (AJCC) staging system for retroperitoneal sarcomas using the National Cancer Data Base (NCDB): does Size matter? Am J Clin Oncol. 2019;42:160–165.
   PubMed Web of Science ®Google Scholar
• Chou YS, Liu CY, Chang YH, et al. Prognostic factors of primary resected retroperitoneal soft tissue sarcoma: analysis from a single asian tertiary center and external validation of gronchi’s nomogram. J Surg Oncol. 2016;113:355–360.
   PubMed Web of Science ®Google Scholar
• MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the trans-atlantic RPS working group. Cancer 2017;123:1971–1978
   PubMed Web of Science ®Google Scholar
• Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res. 2019;25(8):2664-2671.
   Web of Science ®Google Scholar
• Gundle KR, Kafchinski L, Gupta S, et al. Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol. 2018;36:704–709.
   PubMed Web of Science ®Google Scholar
• Strauss DC, Renne SL, Gronchi A. Adjacent, adherent, invaded: a spectrum of biologic aggressiveness rather than a rationale for selecting organ resection in surgery of primary retroperitoneal sarcomas. Ann Surg Oncol. 2018;25:13–16.
   PubMed Web of Science ®Google Scholar
• Fairweather M, Wang J, Jo VY, et al. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol. 2018;25:98–106.
   PubMed Web of Science ®Google Scholar
• Mussi C, Colombo P, Bertuzzi A, et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol. 2011;18:2136–2142.
   PubMed Web of Science ®Google Scholar
• Renne SLTM, Pasquali S, Collini P, et al. Prognostic value of microscopic evaluation of organ infiltration and visceral resection margins (VRM) in patients with retroperitoneal sarcoma (RPS). J Clin Oncol. 2017;35:11074.
   Web of Science ®Google Scholar
• Russo P, Kim Y, Ravindran S, et al. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol. 1997;4:421–424.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.
   PubMed Web of Science ®Google Scholar
• Tseng WH, Martinez SR, Tamurian RM, et al. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: an ACS-NSQIP analysis. J Surg Oncol. 2011;103:390–394.
   PubMed Web of Science ®Google Scholar
• MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS working group. Ann Surg 2018;267:959–964
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19:2981–2991.
   PubMed Web of Science ®Google Scholar
• Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the trans-atlantic RPS working group. Ann Surg Oncol. 2015;22:256–263.
   PubMed Web of Science ®Google Scholar
• Tseng WW, Madewell JE, Wei W, et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014;21:2136–2143.
   PubMed Web of Science ®Google Scholar
• Neuhaus SJ, Barry P, Clark MA, et al. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92:246–252.
   PubMed Web of Science ®Google Scholar
• Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008;113:1657–1665.
   PubMed Web of Science ®Google Scholar
• Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol. 2008;15:1585–1593.
   PubMed Web of Science ®Google Scholar
• Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238: 358–370. discussion 70–1.
   PubMed Web of Science ®Google Scholar
• Radaelli S, Fiore M, Colombo C, et al. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Surg Oncol. 2016;25:125–131.
   PubMed Web of Science ®Google Scholar
• Tseng WW, Tsao-Wei DD, Callegaro D, et al. Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma. Eur J Surg Oncol. 2018;44:810–815.
   PubMed Web of Science ®Google Scholar
• O’Donnell PW, Griffin AM, Eward WC, et al. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer. 2014;120:2866–2875.
   PubMedGoogle Scholar
• Mingoli A, Cavallaro A, Sapienza P, et al. International registry of inferior vena cava leiomyosarcoma: analysis of a world series on 218 patients. Anticancer Res. 1996;16:3201–3205.
   PubMed Web of Science ®Google Scholar
• Wachtel H, Gupta M, Bartlett EK, et al. Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases. Surg Oncol. 2015;24:21–27.
   PubMed Web of Science ®Google Scholar
• Fiore M, Colombo C, Locati P, et al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol. 2012;19:511–518.
   PubMed Web of Science ®Google Scholar
• Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94:1057–1068.
   PubMed Web of Science ®Google Scholar
• Moran CA, Suster S, Koss MN. The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura. Semin Diagn Pathol. 1992;9:169–180.
   PubMed Web of Science ®Google Scholar
• Gholami S, Cassidy MR, Kirane A, et al. Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors. Ann Surg Oncol. 2017;24:3865–3871.
   PubMed Web of Science ®Google Scholar
• Rutkowski PL, Mullen JT. Management of the “Other” retroperitoneal sarcomas. J Surg Oncol. 2018;117:79–86.
   PubMed Web of Science ®Google Scholar
• Kolberg M, Holand M, Agesen TH, et al. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol. 2013;15:135–147.
   PubMed Web of Science ®Google Scholar
• Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French cancer center federation sarcoma group. Cancer. 2001;92:359–368.
   PubMed Web of Science ®Google Scholar
• Casanova M, Ferrari A, Spreafico F, et al. Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol. 1999;21:509–513.
   PubMed Web of Science ®Google Scholar
• Gupta G, Mammis A, Maniker A. Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am. 2008;19:533–543.
   PubMed Web of Science ®Google Scholar
• Mastoraki A, Toska F, Tsiverdis I, et al. Retroperitoneal schwannomas: dilemmas in diagnostic approach and therapeutic management. J Gastrointest Cancer. 2013;44:371–374.
   PubMedGoogle Scholar